Literature DB >> 21848584

Increased TLR2 expression in patients with type 1 diabetes: evidenced risk of microalbuminuria.

Marcela Abbott Galvão Ururahy1, Melina Bezerra Loureiro, Francisco Paulo Freire-Neto, Karla Simone Costa de Souza, Irina Zuhl, José Brandão-Neto, Rosario Dominguez Crespo Hirata, Sonia de Quateli Doi, Ricardo Fernando Arrais, Mario Hiroyuki Hirata, Maria das Graças Almeida, Adriana Augusto de Rezende.   

Abstract

OBJECTIVE: To study the activation of an inflammatory cascade through leukocyte mRNA expression of TLR2, TLR4, MyD88, and pro-inflammatory cytokines in individuals with childhood onset type 1 diabetes. DESIGN AND METHODS: Seventy-six type 1 diabetic patients and 100 normoglycemic subjects (NG) 6 to 20 years old were recruited. Type 1 diabetic patients (DM1) were considered to have good (DM1G) or poor (DM1P) glycemic control according to the values of glycated hemoglobin. TLR2, TLR4, MyD88, interleukin -1β (IL-1β), IL-6, and tumor necrosis factor alpha (TNF-α) mRNA expressions were measured in peripheral blood leukocytes (PBL) by real-time polymerase chain reaction (PCR). Urea, creatinine, albumin, and total protein serum levels were determined. Urinary albumin-to-creatinine ratio (ACR) was calculated.
RESULTS: DM1 and DM1P patients showed higher glycated hemoglobin (10 and 11%, respectively) and serum glucose concentrations (208 and 226 mg/dL, respectively) compared to NG (Glycated hemoglobin: 7% and glucose: 76 mg/dL) (p < 0.05). PBL mRNA expressions of TLR2, MyD88, IL-1β, IL-6, and TNF-α were higher in DM1 and TLR2, IL-1β, and IL-6 expressions were higher in DMP1 compared to NG (p < 0.05). In DM1, serum albumin and total protein were lower, while serum urea and ACR were higher in comparison to NG (p < 0.05). However, these differences compared to NG were more pronounced in DM1P, which included nine individuals with microalbuminuria.
CONCLUSIONS: Increased mRNA expression of TLR2, MyD88, and pro-inflammatory cytokines in leukocytes of patients with childhood onset type 1 diabetes indicates the development of a TLR2-mediated pro-inflammatory process, which may also be associated with an early inflammatory process in the kidney and the occurrence of microalbuminuria.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21848584     DOI: 10.1111/j.1399-5448.2011.00794.x

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  10 in total

1.  IL-6 and type 1 diabetes mellitus: T cell responses and increase in IL-6 receptor surface expression.

Authors:  Karina Braga Gomes
Journal:  Ann Transl Med       Date:  2017-01

Review 2.  TLR2 and TLR4 in autoimmune diseases: a comprehensive review.

Authors:  Yu Liu; Heng Yin; Ming Zhao; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

3.  Chlamydia pneumoniae promotes dysfunction of pancreatic beta cells.

Authors:  Annette R Rodriguez; Germán Plascencia-Villa; Colleen M Witt; Jieh-Juen Yu; Miguel José-Yacamán; James P Chambers; George Perry; M Neal Guentzel; Bernard P Arulanandam
Journal:  Cell Immunol       Date:  2015-04-01       Impact factor: 4.868

Review 4.  Basic Mechanisms of Diabetic Heart Disease.

Authors:  Rebecca H Ritchie; E Dale Abel
Journal:  Circ Res       Date:  2020-05-21       Impact factor: 17.367

5.  Paeoniflorin attenuates incipient diabetic nephropathy in streptozotocin-induced mice by the suppression of the Toll-like receptor-2 signaling pathway.

Authors:  Yun-Xia Shao; Xing-Xin Xu; Kun Wang; Xiang-Ming Qi; Yong-Gui Wu
Journal:  Drug Des Devel Ther       Date:  2017-11-09       Impact factor: 4.162

6.  Association Between a TLR2 Gene Polymorphism (rs3804099) and Proteinuria in Kidney Transplantation Recipients.

Authors:  Shuang Fei; Zeping Gui; Dengyuan Feng; Zijie Wang; Ming Zheng; Hao Chen; Li Sun; Jun Tao; Zhijian Han; Xiaobing Ju; Min Gu; Ruoyun Tan; Xinli Li
Journal:  Front Genet       Date:  2022-02-21       Impact factor: 4.599

Review 7.  Latent Autoimmune Diabetes in Adults (LADA): From Immunopathogenesis to Immunotherapy.

Authors:  Jingyi Hu; Rong Zhang; Hailan Zou; Lingxiang Xie; Zhiguang Zhou; Yang Xiao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-21       Impact factor: 6.055

Review 8.  Type 1 Diabetes Mellitus in the SARS-CoV-2 Pandemic: Oxidative Stress as a Major Pathophysiological Mechanism Linked to Adverse Clinical Outcomes.

Authors:  Aikaterini Kountouri; Emmanouil Korakas; Ignatios Ikonomidis; Athanasios Raptis; Nikolaos Tentolouris; George Dimitriadis; Vaia Lambadiari
Journal:  Antioxidants (Basel)       Date:  2021-05-09

Review 9.  Activation of toll-like receptors and inflammasome complexes in the diabetic cardiomyopathy-associated inflammation.

Authors:  J Fuentes-Antrás; A M Ioan; J Tuñón; J Egido; O Lorenzo
Journal:  Int J Endocrinol       Date:  2014-03-12       Impact factor: 3.257

10.  Increasing toll-like receptor 2 on astrocytes induced by Schwann cell-derived exosomes promotes recovery by inhibiting CSPGs deposition after spinal cord injury.

Authors:  Dayu Pan; Yongjin Li; Fuhan Yang; Zenghui Lv; Shibo Zhu; Yixin Shao; Ying Huang; Guangzhi Ning; Shiqing Feng
Journal:  J Neuroinflammation       Date:  2021-08-09       Impact factor: 8.322

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.